The Singapore National Eye Centre, or SNEC, the Singapore Eye Research Institute, or SERI, and Johnson & Johnson Vision announced a $26.35M research collaboration to tackle myopia, or nearsighted vision, the largest threat to eye health this century. By 2050, half of the world's population are projected to be myopic, with one billion expected to have high myopia, a severe state of the condition that can lead to retinal disease with an increased risk of blindness. The first-of-its-kind public-private strategic partnership in Asia focused on myopia will create a deeper understanding of how the condition develops, how it progresses and how it may be intercepted. It will focus on developing predictive tools to identify those who may be at risk to develop high myopia, conduct research on the underlying mechanisms of myopia, progress novel therapies, and discover and validate methods to prevent the onset and progression of the condition.
